Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CNS International Growth, Ad/Promo Cuts Key Strategies For FY 2003

This article was originally published in The Tan Sheet

Executive Summary

CNS aims to increase international sales by up to 20% in 2002 as part of its strategy to boost revenue and continue recent earnings gains

You may also be interested in...



Sales & Earnings In Brief

Perrigo Q2 results: Private labeler tells analysts Jan. 24 it will take a $1.9 mil. charge in fiscal second quarter ended Dec. 29 due to Kmart's bankruptcy filing. Although shipments to struggling retailer declined in past two months, President and CEO David Gibbons says he expects regular shipping levels to return in February. Company also sold its LaVergne, Tenn. distribution center for $14.2 mil. in Q2. Perrigo three-month cough/cold sales rose 16%, while GI revenues jumped 12% as a result of famotidine 10 mg (Pepcid AC) uptake. Net sales rose 20.6% to $228.7 mil. in Q2, net income jumped over 1,900% to $16.6 mil. Percentages, particularly earnings, reflect year-ago charges due to Perrigo's recall of PPA products...

CNS Breathe Right Sales, FiberChoice Cuts Produce "Return To Profitability"

CNS expects FiberChoice to become a $30 mil. product in the long term, which would equate to about 10% of the fiber category, the company said.

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS093938

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel